» Articles » PMID: 30537044

Preconditioning of Umbilical Cord-derived Mesenchymal Stem Cells by Rapamycin Increases Cell Migration and Ameliorates Liver Ischaemia/reperfusion Injury in Mice Via the CXCR4/CXCL12 Axis

Overview
Journal Cell Prolif
Date 2018 Dec 12
PMID 30537044
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Transfusion of umbilical cord-derived mesenchymal stem cells (UC-MSCs) is a novel strategy for treatment of various liver diseases. However, the therapeutic effect of UC-MSCs is limited because only a few UC-MSCs migrate towards the damaged regions. In this study, we observed the effects of autophagy on the migration of UC-MSCs in vitro and in a model of liver ischaemia/reperfusion (I/R) injury.

Materials And Methods: We investigated the effects of autophagy on the status of the cell, release of anti-inflammatory factors and migration of UC-MSCs in vitro. The therapeutic effects and in vivo migration of rapamycin-preconditioned UC-MSCs were observed in a C57/B6 mouse model of liver I/R injury.

Results: Induction of autophagy by rapamycin enhanced the ability of UC-MSCs to migrate and release anti-inflammatory cytokines as well as increased expression of CXCR4 without affecting cell viability. Inhibition of CXCR4 activation markedly decreased migration of these cells. In a mouse model of liver I/R injury, we found significantly upregulated expression of CXCR12 in the damaged liver. More rapamycin-preconditioned UC-MSCs migrated towards the ischaemic regions than 3-methyladenine-preconditioned or non-preconditioned UC-MSCs, leading to improvement in hepatic performance, pathological changes and levels of inflammatory cytokines. These effects were abolished by AMD3100.

Conclusions: Preconditioning of UC-MSCs by rapamycin afforded increased protection against liver I/R injury by enhancing immunosuppression and strengthening the homing and migratory capacity of these cells via the CXCR4/CXCL12 axis.

Citing Articles

Reduced glutathione enhances adipose tissue-derived mesenchymal stem cell engraftment efficiency for liver fibrosis by targeting TGFβ1/SMAD3/NOX4 pathway.

Yu S, Wang Y, Shi Y, Yu S, Zhao B, Liao N Bioeng Transl Med. 2025; 10(2):e10735.

PMID: 40060764 PMC: 11883125. DOI: 10.1002/btm2.10735.


Engineered EVs from LncEEF1G - overexpressing MSCs promote fibrotic liver regeneration by upregulating HGF release from hepatic stellate cells.

Zhang J, Qiu X, Lei Y, Chen H, Wu D, Wang T Exp Mol Med. 2025; .

PMID: 40025174 DOI: 10.1038/s12276-025-01413-4.


Mesenchymal stem cell-derived extracellular vesicles attenuate ferroptosis in aged hepatic ischemia/reperfusion injury by transferring miR-1275.

Gong Y, You Q, Yuan X, Zeng F, Zhang F, Xiao J Redox Biol. 2025; 81:103556.

PMID: 39986119 PMC: 11893313. DOI: 10.1016/j.redox.2025.103556.


Molecular mechanisms in liver repair and regeneration: from physiology to therapeutics.

Ma X, Huang T, Chen X, Li Q, Liao M, Fu L Signal Transduct Target Ther. 2025; 10(1):63.

PMID: 39920130 PMC: 11806117. DOI: 10.1038/s41392-024-02104-8.


Human studies of the efficacy and safety of stem cells in the treatment of diabetic peripheral neuropathy: a systematic review and meta-analysis.

Alizadeh S, Jahani S, Rezaei Zadeh Rukerd M, Tabrizi R, Masoomi R, Banihashemian S Stem Cell Res Ther. 2024; 15(1):442.

PMID: 39563393 PMC: 11577959. DOI: 10.1186/s13287-024-04033-3.


References
1.
De Witte S, Merino A, Franquesa M, Strini T, van Zoggel J, Korevaar S . Cytokine treatment optimises the immunotherapeutic effects of umbilical cord-derived MSC for treatment of inflammatory liver disease. Stem Cell Res Ther. 2017; 8(1):140. PMC: 5465593. DOI: 10.1186/s13287-017-0590-6. View

2.
Sehgal S . Sirolimus: its discovery, biological properties, and mechanism of action. Transplant Proc. 2003; 35(3 Suppl):7S-14S. DOI: 10.1016/s0041-1345(03)00211-2. View

3.
Kubic J, Lui J, Little E, Ludvik A, Konda S, Salgia R . PAX3 and FOXD3 Promote CXCR4 Expression in Melanoma. J Biol Chem. 2015; 290(36):21901-14. PMC: 4571945. DOI: 10.1074/jbc.M115.670976. View

4.
Sarkar D, Spencer J, Phillips J, Zhao W, Schafer S, Spelke D . Engineered cell homing. Blood. 2011; 118(25):e184-91. PMC: 3242725. DOI: 10.1182/blood-2010-10-311464. View

5.
Li L, Baxter S, Gu N, Ji M, Zhan X . Missing-in-metastasis protein downregulates CXCR4 by promoting ubiquitylation and interaction with small Rab GTPases. J Cell Sci. 2017; 130(8):1475-1485. PMC: 5399787. DOI: 10.1242/jcs.198937. View